Clinical Trials Logo

Clinical Trial Summary

The research procedure is the injection of 20 mL of Ropivacaine solution (vs. saline) to create a paracervical block at the beginning of surgery, while the patient is already under general anesthesia. This injection will take place 3 minutes before the vaginal incision, via 4 injection points. Injections are made 3 mm deep into the vaginal cul de sac. Randomization takes place before surgery by vNOTES: - Experienced group: Local anesthesia with injection of Ropivacaine (20mL of ropivacaine 7.5 mg/mL, i.e. 150mg) and general anesthesia - Control group: Injection of 20mL of placebo (saline) and general anesthesia In both groups, systematic intraoperative and postoperative analgesia will be identical.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05969457
Study type Interventional
Source University Hospital, Rouen
Contact David Mallet
Phone 02 32 88 82 65
Email secretariat.DRC@chu-rouen.fr
Status Not yet recruiting
Phase Phase 3
Start date May 30, 2024
Completion date October 1, 2027

See also
  Status Clinical Trial Phase
Completed NCT01628432 - Effect of Salpingectomy During Conservative Hysterectomy N/A